Toward the defined and xeno-free differentiation of functional human pluripotent stem cell–derived retinal pigment epithelial cells by Vaajasaari, Hanna et al.
Toward the defined and xeno-free differentiation of functional
human pluripotent stem cell–derived retinal pigment epithelial
cells
Hanna Vaajasaari,1 Tanja Ilmarinen,1 Kati Juuti-Uusitalo,1 Kristiina Rajala,1 Niina Onnela,2
Susanna Narkilahti,1 Riitta Suuronen,1,3,4 Jari Hyttinen,2 Hannu Uusitalo,3,4 Heli Skottman1
1Regea - Institute for Regenerative Medicine, University of Tampere, Tampere, Finland; 2Department of Biomedical Engineering,
Tampere University of Technology, Tampere, Finland; 3Department of Eye, Ear, and Oral Diseases, Tampere University Hospital,
Tampere, Finland; 4SILK, Department of Ophthalmology, University of Tampere, Tampere, Finland
Purpose: The production of functional retinal pigment epithelium (RPE) cells from human embryonic (hESCs) and human
induced pluripotent stem cells (hiPSCs) in defined and xeno-free conditions is highly desirable, especially for their use
in cell therapy for retinal diseases. In addition, differentiated RPE cells provide an individualized disease model and drug
discovery tool. In this study, we report the differentiation of functional RPE-like cells from several hESC lines and one
hiPSC line in culture conditions, enabling easy translation to clinical quality cell production under Good Manufacturing
Practice regulations.
Methods: Pluripotent stem cells were cultured on human fibroblast feeder cells in serum-free medium. The differentiation
toward RPE was induced by removing basic fibroblast growth factor and feeder cells from the serum-free conditions. RPE
differentiation  was  also  achieved  using  xeno-free  and  defined  culture  conditions.  The  RPE  cell  morphology  and
pigmentation of the cells were analyzed and the expression of genes and proteins characteristic for RPE cells was evaluated.
In vitro functionality of the cells was analyzed using ELISA measurements for pigment epithelium derived factor (PEDF)
secretion and phagocytosis of photoreceptor outer segments (POS). The integrity of the generated RPE layers was analyzed
using transepithelial electric resistance measurements.
Results: We generated putative RPE cells with typical pigmented cobblestone-like morphology. The expression of RPE-
specific markers was confirmed at the gene and protein level. The differentiated cells were able to phagocytose POS and
secrete PEDF characteristic of native RPE cells. In addition, cultured cells formed a polarized epithelium with high
integrity and exhibited excellent transepithelial electric resistance values, indicating well established, tight junctions.
Moreover, we introduced an improved method to generate functional putative RPE cells without xeno-components under
defined conditions.
Conclusions: We have developed a progressive differentiation protocol for the production of functional RPE-like cells
from hESCs and hiPSCs. Our results demonstrate that putative hESC-RPE and hiPSC-RPE express genes and proteins
characteristic for RPE cells, as well as being able to phagocytose POS and secrete PEDF. Furthermore, our results show
that RPE-like cells can be differentiated in xeno-free and defined culture conditions, which is mandatory for Good
Manufacturing Practice-production of these cells for clinical use.
Retinal pigment epithelium (RPE) is an epithelial cell
monolayer  located  between  the  neural  retina  and
choriocapillaris. RPE provides essential support for the long-
term preservation of retinal integrity and visual functions by
absorbing stray light, regenerating visual pigment, supplying
nutrients, secreting growth factors, and phagocytosing the
shed photoreceptor outer segments (POS) [1]. Dysfunctional
RPE causes impairment and death of the photoreceptor cells,
leading  to  deterioration  or  total  loss  of  vision.  These
mechanisms play an important role in the pathogenesis of
retinal  diseases  like  age-related  macular  degeneration
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(AMD),  which  is  the  leading  cause  of  blindness  in  the
developed world [2]. Intravitreal vascular endothelial growth
factor antagonism has been shown to prevent vision loss and
even improve visual acuity in patients with neovascular AMD
in the early course of the disease. However, in advanced cases
of exudative AMD, as well as in the most common form of
AMD, nonexudative AMD, there is no satisfactory cure. Even
though  vascular  endothelial  growth  factor  antagonists  are
effective, intravitreal injections are needed and this causes
high  costs  for  the  health  care  system  while  exposing  the
patients to complications such as endophthalmitis, myocardial
infarction,  or  stroke  [3].  In  the  search  for  more  a
comprehensive therapy for AMD, tissue engineering and cell
transplantation  are  among  the  most  promising  candidates.
Several cell sources have been considered [4-9].
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558The cellular origin of the retina is exclusively ectodermal.
During development, the first morphological correlates of the
eye  are  the  optic  pit  and  optic  vesicle  with  the  retinal
progenitor cells, and eventually the optic cup with two distinct
layers: the RPE originating from the outer layer, and the neural
retina from the inner layer (Figure 1A). The organization of
the vertebrate retina into well defined layers is a result of a
complex series of developmental processes influenced by a
variety of intrinsic and extrinsic factors. Retinal progenitor
cells give rise to all retinal cell types such as RPE cells,
photoreceptor cells (rods and cones), bipolar cells, ganglion
cells, amacrine and horizontal cells, astrocytes, and Müller
glial cells [10,11].
Human pluripotent stem cells may serve as an unlimited
source of RPE cells for transplantation. Several groups have
reported  successful  RPE  differentiation  originating  from
human embryonic stem cells (hESCs) and human induced
pluripotent stem cells (hiPSCs; summarized in Table 1). It is
widely  acknowledged  that  properties  of  the  existing
pluripotent cell lines vary depending on cell line and culture
conditions  [12-14].  Hence,  it  is  necessary  to  test  RPE
differentiation  methods  and  their  capacities  using  several
different cell lines. The hESC-RPE and hiPSC-RPE have been
shown  to  delay  photoreceptor  loss  and  improve  visual
functions after subretinal transplantations in animal models.
However,  transplanted  cells  disappear  within  first  months
after  transplantation  [4,15-17].  Cell  survival  needs  to  be
improved to maintain the total functionality of the retina. In
addition, these cells have potential in disease modeling and
drug discovery, where they are superior to widely used cell
lines  such  as  human  retinal  pigment  epithelial  cell  line
(ARPE-19),  at  least  resembling  more  closely  their  native
counterparts according to their gene expression [1].
Current differentiation methods for RPE cells mainly rely
on  spontaneous  differentiation  processes  favoring
neuroectodermal lineage, which is characteristic of hESCs
[18-20].  RPE  differentiation  efficiency  has  been  recently
enhanced with a prolonged culture period and cell culture
supplements.  Studied  supplements  include:  nicotinamide
(NIC), Activin A, transforming growth factor beta (TGFβ)
[16], Wnt signaling inhibitor casein kinase I inhibitor (CKI)-7,
dickkopf-related  protein-1  (Dkk-1),  Lefty-A,  fibroblast
growth  factor  antagonist  Y-27632,  and  nodal  signaling
inhibitor SB431542 [21,22]. Regardless of the improvement
of the differentiation efficacy, reaching a sufficient amount of
maturated cells with RPE characteristics still demands long-
term differentiation processes.
Xeno-products  and  undefined  factors  used  in  the
differentiation  processes  pose  further  challenges,  because
animal-derived components may carry factors such as sialic
acid or Neu5Gc, causing unwanted immunogenicity of the
cells [23,24] or even animal pathogens. Fetal bovine serum
(FBS) is widely used, at least in some stages of the culture of
RPE cells (Table 1). KnockOut™ Serum Replacement (KO-
SR), used to replace FBS in many laboratories, still contains
BSA (BSA) and bovine transferrin [25]. In addition, most of
the  published  differentiation  methods  utilize  the  culture
environment produced by mouse embryonic fibroblast (MEF)
cells widely used as feeder cells for hESCs and hiPSCs. It has
been suggested that MEFs may even favor the spontaneous
differentiation process of RPE cells [26]. Recently, Idelson
and coworkers published RPE differentiation from hESCs
cultured on human foreskin fibroblasts (hFFs) and by using
KO-SR in differentiation medium [16], providing the first
important steps toward a defined and xeno-free culture and
differentiation process.
In this study, we demonstrate the differentiation potential
toward RPE cells of four hESC lines and one hiPSC line, and
further give the molecular and functional characterization of
these cells. Human ESC- and hiPSC-derived pigmented cells
show  a  typical  RPE  morphology  and  express  genes  and
proteins that are characteristic for RPE. The monolayer of
putative RPE cells demonstrates functional integrity analyzed
by transepithelial electric resistance (TEER). Additionally,
the cells phagocytose POS and secrete pigment epithelium-
derived factor (PEDF), which is crucial for functional RPE.
In the current study, we introduce a defined and xeno-free RPE
cell differentiation method based on our previously developed
culture system for undifferentiated hESCs and hiPSCs [27].
Such a culture system will be needed in the production of RPE
cells  following  Good  Manufacturing  Practice  for  clinical
applications.
METHODS
Cell lines: We evaluated the RPE differentiation capacity of
four hESC lines: Regea 08/023 (46, XY), Regea 08/017 (46,
XX), Regea 08/056 (46, XX), and Regea 08/013 (46, XY),
which were previously derived in our laboratory, and one
hiPSC line—FiPS 5–7—derived by Professor Otonkoski’s
group at the University of Helsinki, Finland [27,28]. The
hiPSC line FiPS 5–7 was generated from human fibroblasts
using four factors: OCT3/4 (POU5F1), SOX2, nanog, and
LIN28  [27].  Transgene  silencing  was  confirmed  with
quantitative reverse transcription PCR (qRT–PCR) [29]. The
cell lines were cultured at +37 °C in 5% CO2 on mitotically
inactivated  (γ-irradiated,  40  Gy)  hFF  (36,500  cells/cm2;
CRL-2429;  American  Type  Culture  Collection,  ATCC,
Manassas, VA) with basic hESC culture medium. Basic hESC
culture medium consisted of Knockout Dulbecco’s Modified
Eagle Medium containing 20% KO-SR, 2 mM Glutamax,
0.1 mM 2-mercaptoethanol (all from Invitrogen, Carlsbad,
CA), 1% Minimum Essential Medium nonessential amino
acids, 50 U/ml penicillin/streptomycin (both from Cambrex
Bio Science, Walkersville, MD), and 8 ng/ml human basic
fibroblast  growth  factor  (bFGF;  R&D  Systems  Inc.,
Minneapolis,  MN).  The  culture  medium  was  changed  six
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559Figure  1.  Differentiation  of  human
pluripotent  stem  cells  toward  retinal
pigment  epithelium  cells.  A:  A
schematic  representation  of  retinal
pigment  epithelium  (RPE)  cell
differentiation  during  retinal
development. B: Reverse transcription
(RT)–PCR analysis of typical genes for
retinal  development  expressed  during
putative  RPE  differentiation  of  the
human embryonic stem cell (hESC) line
Regea  08/023  and  human  induced
pluripotent stem cell (hiPSC) line FiPS
5–7 at sequential time points on D7–
D72.
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561times  a  week.  Undifferentiated  colonies  were  passaged
manually once a week on the top of hFFs.
Retinal  pigment  epithelium  differentiation  in  serum-free
conditions: To induce spontaneous RPE differentiation, KO-
SR concentration was reduced from 20% to 15% and bFGF
was removed from the basic hESC culture medium (described
above). This modified medium was called RPEbasic. The
cells were cut manually between days 1 and 7 after initiation
of differentiation onto low cell bind six-well plates (Nalge
NUNC,  Tokyo,  Japan),  where  the  cells  formed  floating
aggregates. While the cells were cultured on hFFs, the culture
medium was changed six times a week (2 ml/35×10 mm
polystyrene dish), but for floating cell aggregates, the culture
medium change was reduced to three times a week (3 ml/well
in  a  six-well  plate).  Floating  aggregates  were  passaged
mechanically with a scalpel to make gas and nutrient exchange
possible.  To  gain  purer  RPE  populations,  the  areas  with
pigmented cells were isolated manually with a scalpel and
subsequently  dissociated  with  1×  Trypsin-EDTA  (Lonza,
Walkersville, MD). The cells were seeded either on Collagen
IV (Sigma-Aldrich, St. Louis, MO)-coated 24 well plates for
RT–PCR analyses or on permeable Collagen IV–coated 0.3
cm2 BD Biocoat culture plate inserts (BD Biosciences, San
Jose, CA). After the seeding, the cells were not subcultured.
Retinal pigment epithelium differentiation in xeno-free and
defined conditions: RPE differentiation was studied using a
previously developed xeno-free and defined culture medium
formulation (RegES) [27] as base. For RPE differentiation,
bFGF and retinol were excluded from the published medium
formulation  (RPEregES).  Otherwise,  the  differentiation
method was same as described above (RPEbasic). Analyses
conducted  in  this  study  from  cells  differentiated  using
RPEbasic and RPEregES methods are summarized in Figure
2.
Analyses of pigmentation rates: The appearance of the first
pigmented cells was followed daily. Percentage of pigment
containing cell aggregates from the total amount of aggregates
was counted between days 21 and 30 after induction of the
differentiation. In addition, the day of the first pigmented
cell’s appearance was recorded.
Reverse  transcription  polymerase  chain  reaction:  RNA
samples were collected from cell cultures at five different time
points, on days (D; D7, D28, D44, D52, D72) and, in addition,
on D196, from selected RPE cells (RPEbasic). From cells
differentiated using RPEregES, RNA samples were collected
on D7 and D44. Total RNA was extracted using NucleoSpin
XS-kit (Macherey-Nagel, GmbH & Co, Düren, Germany)
according to the manufacturer’s instructions. Briefly, the cells
were lysed in 102 µl of RA1-TCEP mixture. Five µl of Carrier
RNA working solution was added to the lysate. The sample
was filtrated through the NucleoSpin® Filter Column. One
hundred µl of 70% ethanol was added to the lysate and RNA
bound to the NucleoSpin® RNA XS Column. The column
was desalted using membrane desalting buffer. DNA was
digested  using  DNase  reaction  mixture.  rDNase  was
inactivated with RA2 buffer and silica membrane washed
twice with RA3 buffer. Pure RNA was eluated in 10 µl H2O.
The RNA concentration and quality were assessed with a
NanoDrop  1000  spectrophotometer  (NanoDrop
Technologies, Wilmington, DE). RNA (40 ng) was reverse-
transcribed using MultiScribe Reverse Transcriptase (Applied
Biosystems, Foster City, CA) according to the manufacturer’s
instructions in the presence of RNase inhibitor. Briefly, 10 µl
reaction consisted of: 2.0 µl 10× RT Buffer, 0.8 µl 100 mM
dNTP  Mix,  2  µl  10  µM  gene  specific  primers,  1.0  µl
MultiScribeTM  ReverseTranscriptase,  1.0  µl  RNase
Inhibitor, 11.2 µl Nuclease-free H2O, and 2 µl total RNA (20
ng/µl). The cDNA synthesis was performed as follows: 10 min
at 25 °C, 120 min at 37 °C, 5 s at 85 °C. In addition, genomic
control reactions excluding the enzyme (-RT) for each RNA
sample were performed. CDNA was used as a template in a
following PCR reaction, which was performed using 5 U/μl
Taq DNA Polymerase (Fermentas, Thermo Fisher Scientific
Inc.,  Leicestershire,  UK)  with  5  μM  primers  specific  for
particular genes (Biomers.net GmbH, Söflinger, Germany;
Table 2).
PCR reactions were performed in PCR MasterCycler ep
gradient (Eppendorf AG, Hamburg, Germany) as follows:
after the hot start denaturation at 95 °C for 3 min and 38 cycles
of denaturation at 95 °C for 30 s, 30 s annealing (annealing
Figure 2. A schematic illustration of implementation of the study. Analyses which were done from the RPEregES condition besides the
RPEbasic condition are marked with asterisks (*). Analyses were done from floating aggregate cultures unless marked with gray boxes for
adherent culture.
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562temperature depended on the used primer pair, see Table 2)
and  extension  at  72  °C  for  one  min,  followed  by  final
extension at 72 °C for 5 min. Annealing temperatures and
primer sequences are presented in Table 2. PCR products were
analyzed on 2.0% agarose gels with a 50 bp DNA ladder
(MassRulerTM DNA Ladder Mix; Fermentas). The bands were
visualized with Quantity one 4.5.2. Basic program (Bio-Rad
Laboratories, Inc., Hercules, CA).
Quantitative  reverse  transcription  polymerase  chain
reaction: To further analyze octamer-binding transcription
factor  (OCT)3/4  expression  in  the  selected  hiPSC-RPE
sample after D196 differentiation, we compared expression
levels with the sample from undifferentiated cells of the same
cell line using qRT–PCR. In addition, we analyzed retina and
anterior neural fold homeobox (RAX) expression in FiPS 5–7
with qRT–PCR. RNA isolation and cDNA synthesis were
done as described above, except that cDNA was synthesized
from 200 ng of RNA. FAM-labeled TaqMan Gene Expression
Assays (Applied Biosystems) were used to analyze expression
of the pluripotency marker, OCT3/4 (Hs00999632_g1), and
RAX (Hs00429459_m1). Triplicate reactions were performed
according  to  the  manufacturer’s  instructions.  Synthesized
cDNA was diluted 1:5 in RNase-free water and 3.0 µl was
added  to  the  final  reaction  (15  µl).  The  cDNAs  were
multiplied  using  Applied  Biosystems  7300  Real-time
Sequence Detection System: 2 min at 50 °C, 10 min at 95 °C,
and 40 cycles repeating denaturation for 15 s at 95 °C and
annealing for 1 min at 60 °C. Cycle threshold (Ct) values were
determined  using  7300  System  SDS  Software  (Applied
Biosystems).  The  2ΔΔCt  method  was  used  to  quantify  the
relative  gene  expression  [30].  Replicate  reactions  were
considered reliable if the standard deviation of the triplicates
was  less  than  0.5.  Glyceraldehyde  3-phosphate
dehydrogenase (GAPDH; Hs99999905_m1) was used as an
internal  control  to  normalize  the  added  RNA  amount.
Downregulation is represented using fold regulation, which is
calculated using the following formula: (−1)/fold change.
Immunostaining: After 51 days of differentiation, putative
hESC-RPE  and  hiPSC-RPE  were  seeded  on  permeable
Collagen IV–coated 0.3 cm2 BD Biocoat culture plate inserts
(BD Biosciences) by enzymatic dissociation with 1x Trypsin-
EDTA (Lonza Group Ltd, Basel, Switzerland). Cells were
maturated on inserts for 32 days. For immunostaining, cells
were washed three times with PBS and fixed for 10 min with
4%  paraformaldehyde  (pH  7.4;  Sigma-Aldrich)  at  room
temperature (RT) following repeated washings with PBS. The
cells  were  made  permeable  by  incubating  in  0.1%  Triton
X-100 in PBS (Sigma-Aldrich) at RT for 10 min. Thereafter,
the unspecific binding sites were blocked with 3% BSA (BSA;
Sigma–Aldrich) at RT for 1 h. Samples were incubated for 1
h at RT with primary antibodies; rabbit anti-microphthalmia-
associated  transcription  factor  (MITF)  1:350,  rabbit  anti-
bestrophin 1:500, mouse anti-cellular retinaldehyde-binding
protein (CRALBP) 1:1,000, mouse anti-Na+/K+ATPase 1:50
(all  from  Abcam,  Cambridge,  UK),  mouse  anti-retinal
pigment epithelium-specific 65 kDa protein (RPE65) 1:250,
rabbit anti-Ki67 1:300 (both from Millipore, Bedford, MA),
and mouse anti-zonula occludens 1 (ZO-1) 1:250 (Invitrogen).
The cells were washed three times with PBS and labeled with
1:1,500 diluted secondary antibodies: donkey antimouse IgG
TABLE 2. REVERSE-TRANSCIPTASE (RT)–PCR PRIMER SEQUENCES.
  Primer sequences (5′ > 3′)  
Gene Forward Reverse Tann
GAPDH GTTCGACAGTCAGCCGCATC GGAATTTGCCATGGGTGGA 55
PAX6 AACGACACAGCCCTCACAAACA CGGGAACTTGAACTGGAACTGAC 60
RAX CTGAAAGCCAAGGAGCACATC CTCCTGGGAATGGCCAAGTTT 55
MITF AAGTCCTGAGCTTGCCATGT GGCAGACCT TGGTTTCCAA 52
RPE65 TCCCCAATACAACTGCCACT CACCACCACACTCAGAACTA 52
bestrophin GAATTTGCAGGTGTCCCTGT ATCCTCCTCGTCCTCCTG AT 55
OTX2v1 GGGCCCTGGGCTTCTTGTCC ATTGGCCACTTGTTCCACTC 52
PMEL GTGGTCAGCACCCAGCTTAT GAGGAGGGGGCTATTCTCAC 52
PEDF AGCTCGCCAGGTCCACAAAG TGGGCAATCTTGCAGCTGAG 60
tyrosinase TGCCAACGATCCTATCTTCC GACACAGCAAGCTCACAAGC 52
SOX10 AGCCCAGGTGAAGACAGAGA AGGAGAAGGCCGAGTAGAGG 55
alphafetoprotein GCTGGATTGTCTGCAGGATGGGGAA TCCCCTGAAGAAAATTGGTTAAAAT 55
alpha carciac actin GGAGTTATGGTGGGTATGGGTC AGTGGTGACAAAGGAGTAGCCA 55
nanog TGAAATGTCTTCTGCTGAGAT GTTCAGGATGTTGGAGAGTTC 55
OCT 3/4 CGTGAAGCTGGAGAAGGAGAAGCTG AAGGGCCGCAGCTTACACATGTTC 62
        Abbreviations: Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), paired box gene 6 (PAX6), retina and anterior neural
        fold homeobox (RAX), microphthalmia-associated transcription factor (MITF), anti-retinal pigment epithelium-specific 65 kDa
        protein (RPE65), orthodenticle homeobox 2 variant 1 (OTX2v1), premelanosome protein (PMEL), pigment epithelium-derived
        factor (PEDF), sex determining region Y-box 10 (SOX10).
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563and goat antirabbit IgG, both Alexa Fluor 488, goat antimouse
IgG and goat anti-rabbit IgG, both Alexa Fluor 568 (all from
Molecular  Probes,  Life  Technologies,  Paisley,  UK).
Secondary antibodies were diluted in 0.5% BSA-PBS and
incubated 1.5 h at RT following repeated PBS washings. In
addition, fluorescein isothiocyanate (FITC) phalloidin 1:50
(Invitrogen) was used to label filamentous actin. For clarity,
FITC phalloidin is represented as red in Figure 3H,I,K,L and
A568 is represented as green in Figure 3G,I,J,L. The nuclei
were  stained  with  4´,  6´  diamidino-2-phenylidole  (DAPI)
included in the mounting media (Vector Laboratories Inc.,
Burlingame, CA). Images were taken either with an LSM 700
confocal microscope (Carl Zeiss, Jena, Germany) using a 63×
oil  immersion  objective  or  Olympus  BX60  microscope
(Olympus,  Tokyo,  Japan)  using  a  60×  oil  immersion
objective.
In vitro phagocytosis assay: Porcine POS were isolated to
study whether the cells have the ability to phagocytose POS
[31]. Twenty-three porcine eyes received from a local abattoir
were halved with scissors and the retinas were removed using
tweezers  in  a  dark  room  under  red  light.  Retinas  were
homogenized with homogenizer in 0.73 M sucrose phosphate
buffer.  Homogenized  retinas  were  filtered  and  cell  types
separated in sucrose gradient (0.75 M, 1.0 M, 1.25 M, 1.5 M,
1.75  M)  using  an  ultracentrifuge  (Optima  ultracentrifuge,
Beckman Coulter, Inc., Brea, CA) 60,000× g, 1 h. The pink
POS layer was collected in phosphate buffer and centrifuged.
For  phagocytosis  assay,  sucrose-phosphate  buffer  was
removed  and  POS  were  labeled  with  FITC  (0.04  µg/µl;
Sigma-Aldrich)  in  0.1M  NaHCO3  (pH  9)  for  1  h  at  RT,
following washing three times with PBS and resuspension in
culture  medium.  Floating  cell  aggregates,  which  included
pigmented and nonpigmented cells, were incubated with POS
for  16  h  in  a  cell  culture  incubator  in  culture  medium.
Subsequently, the cells were washed twice with PBS. Cells
were fixed with 4% paraformaldehyde for 30 min at +37 °C
following repeated PBS washings. Thereafter, 0.20% Trypan
Blue was used to quench external fluorescence following PBS
washing.  Cells  were  made  permeable  using  0.1%  Triton
X-100 for 10 min at RT followed by repeated PBS washings.
Filamentous actin was stained with 1:10 diluted phalloidin
0.02 µg/µl (Sigma-Aldrich) by incubating for 10 min at RT
following several PBS washings. The nuclei were stained with
DAPI that was in the mounting media (Vector Laboratories
Inc.). The images of the RPE cells with intracellular POS
fragments were taken using a confocal microscope (LSM 700,
Carl Zeiss, 63× oil immersion objective).
Enzyme-linked immunosorbent assay: The functionality and
maturity of putative RPE cells were evaluated by their PEDF
secretion. RPEbasic and RPEregES media were conditioned
with  10  strongly  pigmented  floating  aggregates  each.
Secretion of nonpigmented aggregates was used as controls.
PEDF secretion was evaluated in four time points; Regea
08/023 was differentiated in RPEbasic conditions for 49, 70,
97, and 230 days, and FiPS 5–7 for 49, 80, 97, and 250 days,
respectively. From the RPEregES condition, analyses were
conducted with both previously mentioned cell lines on days
49 and 98. Culture media were collected from each well every
second  or  third  day.  PEDF  concentration  was  determined
using Chemikine PEDF Sandwich ELISA Kit according to the
instructions of the manufacturer (Millipore). In brief, medium
samples  were  treated  with  8  M  urea  to  gain  total  PEDF
secreted in media and incubated on ice for an hour. Urea-
treated  samples  were  diluted  1:100  in  assay  diluent.  One
hundred µl of diluted samples were added per well of 96 well
plate likewise PEDF standards. Incubated for hour at +37 °C
following  repeated  washing  with  washing  buffer.  1:500
diluted Biotinylated Mouse Anti-Human PEDF monoclonal
antibody was added into the wells. The plate was incubated
for an hour at +37 °C. After repeated washings, 100 µl 1:1000
diluted streptavidin peroxidase conjugate was added to the
wells, following hour incubation at +37 °C. TMB/E reagent
was added to the wells. Incubated at RT for 5–10 min before
addition  of  Stop  Solution,  and  absorbance  was  measured
immediately using Wallac Victor2™ 1420 Multilabel counter
(Perkin Elmer-Wallace, Norton, OH).
Transepithelial electric resistance: Development of epithelia
barrier properties and tight junction formation between the
cells reflecting polarity was determined as duplicates from
hESC-RPE  and  hiPSC-RPE  cell  monolayers  cultured  on
permeable Collagen IV–coated 0.3 cm2 BD Biocoat culture
plate  inserts  (BD  Biosciences).  Human  ESC  line  Regea
08/023 and hiPSC line FiPS 5–7 were differentiated for 178
days and 197 days, respectively, before seeding on the inserts.
TEER measurements were taken every time after replacing
culture media during 90 day culture period of the monolayer
with a Millicell-electrical resistance system volt-ohm meter
(Millipore). TEER (Ωcm2) of the epithelia was obtained by
subtracting the impact of the medium and similarly treated
insert without cells from the result and multiplying this by the
area of the filter membrane.
Ethical issues: Regea-Institute for Regenerative Medicine has
the  approval  of  the  National  Authority  for  Medicolegal
Affairs  Finland  (TEO)  to  study  human  embryos
(Dnro1426/32/300/05). Regea has the support of the Ethical
Committee  of  the  Pirkanmaa  Hospital  District  to  derive,
culture,  and  differentiate  hESC  lines  from  surplus  human
embryos (R05116).
RESULTS
Comparison of the differentiation rate between cell lines: In
this study, we successfully differentiated RPE-like cells from
all five human pluripotent stem cell lines that were studied.
First, the differentiation potentials of the hESC lines and the
hiPSC line were compared by analyzing the appearance of the
first  pigmented  cells  emerging  from  each  cell  line.  On
average, pigmentation was observed as follows: Regea 08/013
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564Figure 3. Immunofluorescence staining of human embryonic stem cell (hESC; Regea 08/023)- and human induced pluripotent stem cell
(hiPSC; FiPS 5–7)-derived retinal pigment epithelium cells revealing maturation stage after 83 days of differentiation. Cellular retinaldehyde-
binding protein (CRALBP) and microphthalmia-associated transcription factor (MITF) localization in A-C: manually selected hESC-RPE
cells and D-F: hiPSC-retinal pigment epithelium (RPE) cells. G, I: RPE65 expression in hESC-RPE and J, L: hiPSC-RPE. H, K: For cell
morphology, F-actins were stained using phalloidin. Tight junction protein anti-zonula occludens (ZO)-1 and proliferation marker Ki67
localization in M: hESC-RPE cells and N: hiPSC-RPE cells. Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI). Images A-F
were taken with an Olympus BX60 microscope (Olympus, Tokyo, Japan) using a 60× oil immersion objective, scale bar 20 μm. Images G-
N were taken with an LSM 700 confocal microscope (Carl Zeiss) using a 63× oil immersion objective, scale bar 20 μm.
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565on D21, both Regea 08/017 and Regea 08/023 on D12, Regea
08/056  on  D10,  and  FiPS  5–7  on  D11  (Table  3).  The
percentage of pigmented cell clusters from each cell line was
calculated between day 21 and 28 after the removal of bFGF
(RPEbasic). Over 20% of the cell aggregates of the cell lines
Regea  08/023,  Regea  08/056,  and  FiPS  5–7  contained
pigment cells, whereas less than 10% of the aggregates of the
cell lines Regea 08/013 and Regea 08/017 contained pigment
cells (Table 3).
Eye-specific  gene  expression  during  differentiation:  Gene
expression of the differentiating cells was analyzed using RT–
PCR (Table 4). All of the hESC lines expressed the early eye
lineage markers paired box gene 6 (PAX6) and RAX, and early
RPE  marker  MITF  seven  days  after  removal  of  bFGF
(RPEbasic). In contrast, the expression of RAX by the FiPS 5–
7 cell line could not be consistently detected until D56. Thus,
we further studied RAX expression with qRT–PCR. qRT–PCR
analyses  showed  that  RAX  was  expressed  on  D7  and  the
expression decreased during differentiation (Figure 4). The
RPE  cell  specific  markers  RPE65  and  Bestrophin  were
detected from all the cell lines on D7–D28 except for cell line
Regea  08/013,  from  which  the  expression  of  RPE65  was
detected for the first time on D44. Other RPE cell markers,
orthodenticle  homeobox  2  variant  1  (OTX2v1),
premelanosome protein (PMEL), and PEDF were expressed
relatively  early  during  the  differentiation  process,  with
tyrosinase showing the latest appearance of the studied genes.
Representative  RT–PCR  results  from  hESC  line  Regea
08/023 and hiPSC line FiPS 5–7 are presented in Figure 1B.
Pigmented  cells  expressed  retinal  pigment  epithelium–
specific genes and proteins: According to the pigmentation
rate (Table 3), we chose the hESC line Regea 08/023 and
TABLE 3. PIGMENTATION RATE OF STUDIED CELL LINES.
Cell line Appearance of pigmentation±
standard deviation (n)
Number of pigmented cell
aggregates
Total number of cell
aggregates
% Pigmented
aggregates
08/013 d21±3.2 (5) 90 949 9.5
08/017 d12±7.4 (4) 50 775 6.5
08/023 d12±5 (6) 136 582 23.4
08/056 d10±2.1 (2) 55 249 22.1
FiPS 5–7 d11±5.3 (3) 83 333 24.9
          n: number of independent experiments
TABLE 4. GENE EXPRESSION PROFILES DURING THE DIFFERENTIATION.
Cell line Day GAPDH PAX6 RAX MITF RPE65 bestrophin OTX2v1 PMEL PEDF tyrosinase
08/013 d7 + + (+) + - - + + + -
08/013 d28 + + + + - + + + + -
08/013 d44 + + + + + + (+) + + +
08/013 d52 + + + + + + (+) + + +
08/013 d72 + + + + + + (+) + + +
08/017 d7 + + + + - - + (+) + -
08/017 d28 + + (+) + + + + + + -
08/017 d44 + + + + + + + + + -
08/017 d52 + + - + + + + + + +
08/017 d72 + + + + + + + + + +
08/023 d7 + + + + - (+) + + + -
08/023 d28 + + + + + (+) + + + -
08/023 d44 + + + + + + + + + (+)
08/023 d52 + + + + + + + + + (+)
08/023 d72 + + + + + + + + + (+)
08/056 d7 + + (+) + + + + + + -
08/056 d27 + + + + + + + + + +
08/056 d44 + + + + + + + + + +
08/056 d54 + + + + + + + + + +
08/056 d72 + + + + + + + + + +
FiPS 5–7 d7 + + - + - + + + + -
FiPS 5–7 d28 + + - + + + + + + -
FiPS 5–7 d44 + + - + + + (+) + + -
FiPS 5–7 d56 + + (+) + + + + + + +
FiPS 5–7 d72 + + + + + + + (+) + (+)
        In the table + means positive expression, (+)means faint expression, - means negative expression. Abbreviations: Glyceraldehyde
        3-phosphate  dehydrogenase  (GAPDH),  paired  box  gene  6  (PAX6),  retina  and  anterior  neural  fold  homeobox  (RAX),
        microphthalmia-associated  transcription  factor  (MITF),  anti-retinal  pigment  epithelium-specific  65  kDa  protein  (RPE65),
        orthodenticle homeobox 2 variant 1 (OTX2v1), premelanosome protein (PMEL), pigment epithelium-derived factor (PEDF).
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566hiPSC  line  FiPS  5–7  for  more  detailed  evaluation.  The
isolated pigmented cells were matured on Collagen IV–coated
well  plates.  Morphologically,  cultured  cells  seemed  to
undergo  an  epithelial-mesenchymal  transition  (EMT)
process;  after  attachment,  cells  had  fibroblast-like
morphology following transition to round cells and finally to
morphologically typical cobblestone-like cells, putative RPE
cells with pigment granules (Figure 5A). The isolated and
long-term cultured (d196) hESC- and hiPSC-derived RPE-
like  cells  expressed  the  typical  RPE  cell  genes  (MITF,
RPE65, bestrophin, OTX2v1, PMEL, PEDF, and tyrosinase;
Figure  5B).  Of  the  studied  genes,  undifferentiated  cells
showed the expression of PMEL, PEDF, SOX10, alphacardiac
actin, nanog, and OCT3/4. hFF used in undifferentiated cell
cultures  showed  the  expression  of  PMEL,  PEDF,  and
SOX10  (Figure  5B).  In  addition,  the  cells  expressed  eye
precursor gene PAX6; however, RAX showed only very faint
expression. The endodermal marker alphafetoprotein was not
expressed  in  long-term  cultured  cell  population,  but
mesodermal  marker  alphacardiac  actin  was  expressed  by
hiPSC-RPE  cells  and  a  marker  of  neural  crest-derived
melanocytes (SOX10) was expressed by both cell lines. In
addition, the expression of the pluripotent markers nanog and
OCT3/4 was detected from hiPSC-RPE but was absent in
hESC-RPE  cells  (Figure  5B).  However,  qRT–PCR
comparison  between  undifferentiated  FiPS  5–7  cells  and
putative hiPSC-RPE cells showed that the expression level
was very low on D196 of differentiation (Figure 5C).
To confirm that the manually isolated cells expressed
proteins  typical  of  functional  RPE,  the  expression  and
localization  of  MITF,  CRALBP,  RPE65,  and  ZO-1  were
analyzed with immunostaining (Figure 3). MITF localized in
the  nuclei  and  CRALBP  both  to  the  cytoplasm  and  cell
membrane (Figure 3A,D), as expected. RPE65 was observed
in cytoplasm. Phalloidin staining showed F-actin distribution
adjacent to the cell membrane, resembling native RPE cells
(Figure 3H,K). ZO-1 localized to the tight junctions on the
cell membrane and Ki-67 staining was negative, suggesting
that cells were mature and did not proliferate at this stage
(Figure 3M,N).
Functional  characterization  of  differentiated  cells:  The
functionality  of  putative  hESC-RPE  (Regea  08/023)  and
hiPSC-RPE (FiPS 5–7) was shown by POS phagocytosis,
PEDF secretion, polarization of cells, and the integrity of the
epithelial structure by TEER measurements. The results show
that pigmented cells from both lines were able to phagocytose
POS (Figure 6A,B), as opposed to nonpigmented cells, which
were used as controls (data not shown).
Pigmented cell aggregates differentiated with RPEbasic
method also secreted PEDF to the culture medium, whereas
nonpigmented cells did not. On average, PEDF secretion after
49 days of differentiation was 1.7 ng/ml from putative hESC-
RPE (Regea 08/023) and 13.8 ng/ml from putative hiPSC-
RPE (FiPS 5–7). On D70, the secretion was increased to 77.5
ng/ml from putative hESC-RPE (Regea 08/023) cells and 44.8
ng/ml from putative hiPSC-RPE (FiPS 5–7) cells on D80,
respectively. After 97 days of differentiation, PEDF secretion
was 548.0 ng/ml (Regea 08/023) and 251.8 ng/ml (FiPS 5–7).
After 230 days of differentiation, secretion was 434 ng/ml
from hESC-RPE cells. From hiPSC-RPE-like cells, secretion
was 15.5 ng/ml on D250. It must be noted that the exact cell
amount was not the same between media collections. hFF
cells, which were used as feeder cells for pluripotent cells, also
showed PEDF expression at the gene level, but did not secrete
a detectable amount of PEDF to the culture medium (data not
shown).
The polarization of the cells was analyzed by localization
of  Na+/K+ATPase  and  bestrophin  proteins.  Na+/K+ATPase
was localized on the apical cell membrane and Bestrophin on
Figure 4. Retina and anterior neural fold
homeobox (RAX) expression by FiPS
5–7  during  differentiation.
Undifferentiated cells (D0) have been
used as a reference sample.
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567Figure  5.  Morphology  and  gene
expression  analysis  of  manually
selected and long-term cultured human
embryonic  stem  cell  (hESC)-retinal
pigment  epithelium  (RPE;  Regea
08/023)  and  hiPSC-RPE  (FiPS  5–7)
cells.  A:  Bright-field  micrograph  of
hESC-retinal pigment epithelium (RPE)
and  human  induced  pluripotent  stem
cell (hiPSC)-RPE cells cultured for 136
days  on  Collagen  IV.  The  cells  have
acquired a cobblestone morphology and
a high degree of pigmentation, which is
typical of RPE cells. Low magnification
images  were  captured  with  a  Nikon
Eclipse  TE2000-S  phase  contrast
microscope (Nikon Instruments Europe
B.V. Amstelveen, The Netherlands) and
higher  magnification  images  with  an
Olympus BX60 microscope (Olympus,
Tokyo,  Japan)  using  a  60×  oil
immersion objective. Scale bar 20 μm.
B:  Reverse  transcription  (RT)–PCR
analysis showing the expression of optic
vesicle,  optic  cup,  RPE,  neural  crest
melanocyte,  pluripotent  stem  cell,
mesoderm and endoderm marker genes
by undifferentiated cells (D0), human
foreskin  fibroblast  (hFF)  feeder  cells,
and  putative  RPE  cells  (D196)  from
Regea 08/023 and FiPS 5–7 cells. N/
A=not  analyzed.  C:  Relative  OCT3/4
expression  between  undifferentiated
FiPS 5–7 and putative hiPSC-RPE after
196 days of differentiation.
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568the  basolateral  side,  demonstrating  the  polarization  of
analyzed cells (Figure 6C,D).
The development of the integrity of the epithelia was
assessed weekly during a 90 day period after seeding the cells
on  porous  culture  inserts.  Thirty  days  after  plating  the
pigmented cells on the inserts, TEER values ranged between
6 and 32 Ωcm2 and were 6–10 Ωcm2 in hESC-RPE (Regea
08/023) and hiPSC-RPE (FiPSC 5–7), respectively. After 60
days on inserts, TEER values ranged between 145 and 188
Ωcm2  for  putative  hESC-RPE  and  were  23–38  Ωcm2  for
Figure 6. Phagocytosis of photoreceptor outer segments (POS) and cell membrane polarization of human embryonic stem cell (hESC; Regea
08/023) and human induced pluripotent stem cell (hiPSC; FiPS 5–7)-derived retinal pigment epithelium (RPE) cells. A: Putative hESC-RPE
and B: hiPSC-RPE internalize POS (green, arrowheads) for cell morphology; F-actins were stained using phalloidin (red). Vertical confocal
sections showing apical localization of Na+/K+ATPase (green) and basolateral localization of Bestrophin (red) in C: hESC-RPE and D: hiPSC-
RPE. Images were taken with an LSM 700 confocal microscope (Carl Zeiss) using a 63× oil immersion objective, scale bar 20 μm.
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569putative hiPSC-RPE. After 90 days on the inserts, TEER
values for hESC-RPE reached 311 Ωcm2 and for hiPSC-RPE,
74 Ωcm2.
Xeno-free  and  defined  conditions  induce  efficient  retinal
pigment  epithelium  differentiation:  Finally,  we  wanted  to
evaluate  RPE  differentiation  in  defined  and  xeno-free
conditions (RPEregES) and to compare this with our findings
in basic conditions (RPEbasic). The results from a pilot study
with  the  Regea  08/013  cell  line,  which  was  derived  and
maintained in RegES [27], indicated that hESCs derived and
maintained in RegES are able to spontaneously differentiate
into  pigmented  cells  resembling  RPE  morphology  when
bFGF  is  excluded  (data  not  shown).  To  compare  the
RPEregES method with RPEbasic, we implemented further
studies with Regea 08/023 and FiPS 5–7. The first pigmented
cells were observed in hESC line Regea 08/023 on D7 and in
hiPSC  line  FiPS  5–7  on  D6  in  RPEregES  conditions,
compared to D12 and D11, respectively, in RPEbasic. The
ratio of the pigmented cell clusters (n) was evaluated after 23–
28 days of differentiation. The percentage of the pigmented
clusters for FiPS 5–7 cells was 37% (n=129) in RPEregES
conditions and 25% (n=457) in RPEbasic conditions, and for
Regea  08/023  cells  43%  (n=129)  in  RPEregES  and  25%
(n=645) in RPEbasic conditions.
RT–PCR and immunostainings were performed for the
cells  (Regea  08/023  and  FiPS  5–7)  differentiated  in
RPEregES  medium.  On  D44,  cells  from  both  cell  lines
expressed  all  analyzed  eye/RPE-specific  markers  (PAX6,
RAX,  MITF,  RPE65,  bestrophin,  OTX2v1,  PMEL,  PEDF,
tyrosinase;  Regea  08/023,  Figure  7A;  FiPS  5–7,  data  not
shown). The pigmented cells in RPEregES conditions were
manually selected on D51. Their morphology and protein
expression  were  analyzed  on  D83.  The  pigmented  cells
differentiated  from  both  hESC  and  hiPSC  lines  had
cobblestone-like morphology, which is typical for RPE cells.
In addition, the cells were positive for RPE65, ZO-1, MITF,
CRALBP,  Bestrophin,  and  Na+/K+ATPase,  which  are
important for the functionality of the RPE cell. There were
some Ki67 positive cells, which were clearly more immature
according to the cell morphology (Regea 08/023, Figure 7B-
I; FiPS 5–7, data not shown). In addition to gene and protein
expression, putative RPE cells differentiated with RPEregES
secreted PEDF. On average, PEDF secretion after 49 days of
differentiation was 16.2 ng/ml and 97 days was 182.4 ng/ml
DISCUSSION
In this study, we successfully differentiated RPE-like cells
from several human pluripotent stem cell lines without the use
of animal cells or serum during the differentiation. In addition,
we  reported  RPE  differentiation  in  xeno-free  and  defined
culture conditions. Putative RPE cells arise spontaneously
from undifferentiated cells by the removal of bFGF from the
culture conditions. The hESC lines used in this study have a
similar background; all the cell lines were cultured on hFF
feeder cells and in KO-SR containing culture medium without
serum. The hiPSC line, FiPS 5–7, was cultured on top of hFF
feeder cells from passage 26 onwards. Other published RPE
differentiation  methods  have  harnessed  mainly  hESC  and
hiPSC lines derived and cultured on MEFs or with FBS (Table
1). Only very recently, Idelson and coworkers published a
protocol differentiating hESCs toward RPE cells from hESCs
grown on hFF feeder cells and with KO-SR containing culture
medium [16].
Our results demonstrate that the appearance of the first
pigmented cells was relatively fast after the removal of bFGF,
both in hESC and hiPSC lines, varying from 10 to 21 days.
Most of the published data describe the appearance of the first
pigmented cells usually around 2 to 8 weeks [1,32,33]. Thus,
according to their pigmentation, hESCs and hiPSCs cultured
on hFF seem to have equally good differentiation rate to those
of other published cell lines cultured on MEFs. We analyzed
the  percentage  of  the  pigment  containing  cell  clusters  to
indicate the differentiation rate of each cell line on D21–D28
after initiation of the differentiation. Although calculations
only give a rough estimate of the pigmentation rate, the results
demonstrated differences between analyzed cell lines. Idelson
and coworkers published comparable results with an equal
amount of pigmented cell clusters (<15%) after four weeks of
differentiation  without  NIC  supplementation  [16].  For
comparison,  Klimanskaya  and  coworkers  reported  the
presence  of  pigmented  islands  in  less  than  1%  of  hESC-
derived cell aggregates after 4–8 weeks of differentiation [1].
During the time course of differentiation, we already
detected the expression of early eye lineage markers PAX6
and RAX, as well as early RPE marker MITF at D7 after
removal of bFGF from all analyzed hESC lines. Although the
expression of PAX6 was also detected during a later stage of
the differentiation, our data demonstrated that the mature RPE
cell specific markers, RPE65 and bestrophin, were detected
from all but one of the hESC lines on D28 at the latest. In
addition, other RPE cell markers—OTX2v1, PMEL, PEDF,
and  tyrosinase—were  also  expressed  early  in  the
differentiation process of hESC lines, with tyrosinase having
the latest appearance of the studied genes. Surprisingly, the
expression of RAX was not detected from hiPSC-RPE (FiPS
5–7) until D56. On the other hand, RPE cell specific markers
RPE65, bestrophin, OTX2v1 PMEL, PEDF, and tyrosinase
were expressed in hiPSC-RPE derived cells similarly as to
hESC-RPE cells.
According to the pigmentation rate, we chose the most
promising hESC line, Regea 08/023, and hiPSC line, FiPS 5–
7, for more detailed evaluation. Manually selected and long-
term  cultured  cells  formed  a  monolayer  of  pigmented
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from hESC-RPE (Regea 08/023) cells. Corresponding values
from  hiPSC-RPE  (FiPS  5–7)  differentiated  with  the
RPEregES method were 10.6 ng/ml and 463.15 ng/ml.cobblestone-like cells that had a very similar morphology to
previously published hESC-RPE and hiPSC-RPE cells [1,
32,34]. After dissociation into single cells, the differentiated
RPE-like cells started to proliferate and were observed to
undergo morphological changes that are typical in EMT. EMT
is related to normal development and tissue repair, but also
pathological  processes  such  as  cancer  and  proliferative
vitreoretinopathy.  The  EMT  process  has  been  recently
described in isolated RPE cells [35]; thus it is a natural feature
when RPE cells lose cell-cell contacts. Our results indicate
that putative hESC-RPE and hiPSC-RPE cells also seem to
undergo a similar process.
The gene expression analyses of hESC-RPE and hiPSC-
RPE cells revealed that the cells expressed eye precursor
genes RAX and PAX6, and RPE cell markers. The expression
of RAX was not constantly detected from hiPSC-RPE (FiPS
5–7) until D56 with RT–PCR. However, more quantitative
qRT–PCR analysis showed that RAX expression was similar
to that of hESC-RPE cells. Both cell lines also expressed the
marker  of  neural  crest-derived  melanocytes  (SOX10),
indicating  the  presence  of  other  ectoderm  derivatives.
SOX10 expression by selected hESC and hiPSC derived RPE-
like cells is most probably the expression of other types of
neural cells, which easily contaminate pluripotent human cell
cultures [36]. Selected and long-term cultured hiPSC-RPE
cells expressed mesodermal marker and pluripotent marker
OCT3/4  and  nanog,  indicating  that  the  cell  population
contained  undifferentiated  cells.  We  showed  that  neither
hESC-RPE nor hiPSC-RPE were homogenous, even after 196
days  in  culture,  according  to  gene  expression,  although
Figure 7. Differentiation of human pluripotent stem cells toward retinal pigment epithelium (RPE) cells under defined culture conditions,
RPEregES. All represented images are from human embryonic stem cell (hESC)-RPE Regea 08/023. A: Reverse transcription (RT)–PCR
analysis of typical genes for retinal/ RPE development expressed by undifferentiated hESC (Regea 08/023), human foreskin fibroblast (hFF)
feeder cells, and putative hESC-RPE on D7 and D44. Expression of B: Microphthalmia-associated transcription factor (MITF), B: Cellular
retinaldehyde-binding protein (CRALBP), and E,G: RPE65 on D83. F: For cell morphology, F-actins were stained using phalloidin. H:
Proliferative activity was studied by Ki67 staining together with tight junction protein anti-zonula occludens (ZO)-1 in hESC-RPE. I: Vertical
confocal sections showing apical localization of Na+/K+ATPase (green) and basolateral localization of Bestrophin (red). Nuclei stained with
4',6-diamidino-2-phenylindole (DAPI). Images B-D were taken with an Olympus BX60 microscope (Olympus, Tokyo, Japan) using a 60×
oil immersion objective, scale bar 20 μm. Images E-I were taken with an LSM 700 confocal microscope (Carl Zeiss) using a 63× oil immersion
objective, scale bar 20 μm.
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571morphologically the cells seemed to be of uniform quality.
Thus, the manual selection, which we used in this study, is not
sufficient to gain a pure population of putative RPE cells.
Consequently,  it  is  essential  to  develop  more  specific
differentiation methods and more efficient purification and
selection methods for these cells.
Microscopy of cells differentiated for 83 days showed
that  the  cells  were  highly  organized  and  pigmented.  The
immunocytochemical  localization  of  proteins  essential  for
mature and functional RPE cells was identical to previously
described results [16,37]. Of note, the cells expressed RPE65,
which is essential for the regeneration of the visual pigment
required for both rod- and cone-mediated vision [38]. The
expression of the RPE65 protein is typically lost in cultured
RPE cells [39-41], and has been reported in only a few papers
describing the differentiation of RPE cells from human ESCs
[16,37].  The  expression  of  RPE65  protein  in  a  culture
environment  by  human  iPSC-RPE  has  been  previously
reported only by western blotting and was detected as late as
after eight months of differentiation [32]. In the present study,
both  hESC-RPE  and  hiPSC-RPE  cells  showed  RPE65
immunostaining  at  D83,  suggesting  that  the  differentiated
cells are functional and closely resemble the native RPE cells.
One of the most important functions of the RPE cells is
the phagocytosis of POS. In vivo, photoreceptor cells undergo
a daily renewal process and RPE cells take care of the waste
disposal  by  phagocytosing  nonfunctional  POS.  Several
groups have published the phagocytotic activities of hESC-
RPE and hiPSC-RPE in vitro using latex beads [1] or POS
isolated from animals [32,42]. It has been further suggested
that the only proof for the specific phagocytosis activity of
RPE cells is the capability for POS phagocytosis [42]. The
hESC-RPE  and  hiPSC-RPE  cells  generated  in  our  study
possess  the  relevant  molecular  functions  required  for  the
phagocytosis  of  isolated  POS,  thus  demonstrating  their
functionality in vitro.
In addition, the functionality of hESC-RPE and hiPSC-
RPE  cells  was  shown  by  PEDF  secretion,  with  both
differentiation methods described here. PEDF secreted by
RPE cells is antiangiogenic and neuroprotective, protecting
retinal  neurons  from  light  damage,  oxidative  stress,  and
glutamate excitotoxicity [43]. According to our knowledge,
the secretion of PEDF from putative hESC-RPE or hiPSC-
RPE cells has not been previously published anyone other than
Klimanskaya and coworkers [1]. Our data demonstrated that
the differentiated pigmented cells were able to secrete high
levels of PEDF into the culture medium, while nonpigmented
cells did not secrete any detectable amounts of PEDF. There
is no published data about the amount of PEDF secreted by
putative  hESC/hiPSC-RPE  [1].  Tong  and  coworkers  have
reported that the ARPE19 line secretes PEDF at around the
5–35 ng/ml level to the culture medium [44], and Maminishkis
and coworkers have stated that isolated human fetal RPE cells
secrete PEDF at the 600 ng/ml level [45]. These levels have
not  been  standardized  to  the  cell  number  included  in  the
experiment;  thus,  direct  comparison  of  our  results  is  not
possible. However, the hESC-RPE and hiPSC-RPE cells in
our study secrete reasonable levels (40 ng/ml- 430 ng/ml) of
PEDF, demonstrating their functionality in relation to growth
factor production in vitro.
Versatile  determination  of  the  maturation  and
polarization capacity of the derived cells in a specific culture
protocol is important [32]. TEER is one of the assessments
that can be used for this [46]. TEER values have been regularly
assessed from human retinal explants [47] and primary and
immortalized  RPE  cell  lines  reaching  206  Ωcm2  and  100
Ωcm2, respectively [48,49]. To our knowledge, the TEER of
putative hESC-RPE or hiPSC-RPE cells has not yet been
evaluated.  In  our  culture,  the  putative  hESC-RPE  cells
reached  TEER  values  of  310  Ωcm2  after  268  days  of
differentiation  and  the  putative  hiPSC-RPE  cells  reached
TEER values of 74 Ωcm2 after 287 days of differentiation.
When the TEER values of hESC/hiPSC-RPE are compared to
values derived from other RPE cell cultures, it appears that
putative hESC-RPE cells are at least as good or even superior
to immortalized RPE cell lines in forming a highly polarized
monolayer. Further indications of a high degree of cellular
polarization of differentiated cells are the separation of Na+/
K+ATPase to the apical and bestrophin to the basal side of the
cellular monolayer, and junctional localization of apical tight
junction protein ZO-1.
We  further  demonstrated  that  xeno-free  and  defined
differentiation conditions can be used for the induction and
maturation of pluripotent stem cell derived RPE cells. With
this method, we were able to differentiate RPE-like cells from
hESCs and hiPSCs. The differentiated cells showed similar
gene  and  protein  expression  profiles,  as  well  as  cellular
polarization, to the RPE cells differentiated using RPEbasic
conditions  containing  xenogeneic  substances.  Our  results
demonstrated that the appearance of the pigmented cells was
slightly faster in RPEregES conditions as compared to the
cells in RPEbasic conditions. In addition, the percentage of
the pigmented clusters after 23 days of differentiation of both
the  hESC  and  hiPSC  lines  were  higher  in  RPEregES
conditions, with the hiPSC line having over 10% difference
between the two conditions. These results suggested that our
defined and xeno-free culture medium described previously
[27] may even enhance the differentiation of RPE cells. This
may be partly explained by the fact that the medium contains
Activin A (5 ng/ml), a known inducer of RPE cell fate [26].
Our defined and xeno-free differentiation method is one step
forward  when  optimizing  proper  culture  conditions  for
clinically eligible RPE cells for transplantation. It remains to
be studied whether supplements such as NIC [16] and Wnt
and Nodal antagonists [21,22] increase RPE differentiation
from hESCs and hiPSCs in our culture systems.
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572In  conclusion,  we  have  demonstrated  a  progressive
differentiation protocol for the production of functional RPE-
like cells from hESCs and hiPSCs. Our results demonstrate
that putative hESC-RPE and hiPSC-RPE express genes and
proteins characteristic for RPE cells, can phagocytose POS,
are able to secrete PEDF and form highly polarized and tight
epithelial structures in vitro. Our results show that highly
mature RPE-like cells can be differentiated in xeno-free and
defined culture systems that are easier to translate under the
Good Manufacturing Practice production systems needed for
clinical  use.  Furthermore,  defined  conditions  will  greatly
elucidate  the  further  development  of  more  efficient
differentiation protocols and the use of cells in drug screening
and toxicology studies.
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